https://doctransparency.com/doctor/tx/schertz/manuel-ybarra-1053572503
Medicare Enrolled

Dr. Manuel Ybarra, MD

Anesthesiology · Schertz, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
6051 FM 3009 STE 210, Schertz, TX 78154
2102997770
In practice since 2008 (17 years)
NPI: 1053572503 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Ybarra from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ybarra? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Ybarra

Dr. Manuel Ybarra is an anesthesiology in Schertz, TX, with 17 years in practice. Based on federal Medicare data, Dr. Ybarra performed 11,390 Medicare services across 4,066 unique beneficiaries.

Between the years covered by Open Payments, Dr. Ybarra received a total of $37,671 from 58 pharmaceutical and/or device companies across 1126 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in anesthesiology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Ybarra is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 17 years in practice▲ Top 0% volume in TX$ $37,671 industry payments

Medicare Practice Summary

Medicare Utilization ↗
11,390
Medicare services
Top 0% in TX for anesthesiology
4,066
Unique beneficiaries
$67
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~670 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Dexamethasone injection (steroid)2,622$0$1
Injection, midazolam hydrochloride, per 1 mg1,949$0$1
Office visit, established patient (20-29 min)1,654$66$266
Office visit, established patient (30-39 min)1,367$92$376
Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes350$38$149
Injection, methylprednisolone acetate, 40 mg346$6$21
Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level260$217$739
Injection of lower or sacral spine facet joint using imaging guidance, single level218$194$519
Injection, methylprednisolone acetate, 80 mg213$9$35
Injection of lower or sacral spine facet joint using imaging guidance, second level192$97$270
Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint187$488$1,330
New patient office visit (30-44 min)181$82$327
Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance179$143$483
Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint175$222$736
Joint injection, major joint172$53$189
Fluoroscopic guidance for needle placement167$86$347
Injection, ketorolac tromethamine, per 15 mg112$0$2
New patient office visit (45-59 min)99$119$489
Injection of upper or middle spine facet joint using imaging guidance, single level96$209$566
Office visit, established patient (10-19 min)93$43$165
Injection of substance into middle or upper spine canal using imaging guidance92$197$787
Injection of upper or middle spine facet joint using imaging guidance, second level89$104$286
Injection of trigger points, 3 or more muscles80$45$181
Telephone medical discussion with physician, 11-20 minutes71$64$265
Destruction of upper or middle spinal facet joint nerves using imaging guidance, each additional facet joint57$228$794
Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level56$88$335
Destruction of upper or middle spinal facet joint nerves using imaging guidance, single facet joint56$471$1,317
Injection of substance into lower spine canal using imaging guidance52$192$775
Drug injection, under skin or into muscle42$10$42
Insertion of spinal neurostimulator electrode array through skin38$1,596$7,021
Telephone medical discussion with physician, 21-30 minutes28$94$295
Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes25$8$31
Insertion of spinal neurostimulator electrode array using fluoroscopic guidance22$511$2,030
New patient office or other outpatient visit, 15-29 minutes22$54$213
Telephone medical discussion with physician, 5-10 minutes17$43$164
Injection of trigger points, 1-2 muscles11$41$157
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$37,671
Total received (2018-2024)
Avg $5,382/year across 7 years
Top 1% in TX for anesthesiology
58
Companies
1,126
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$37,671 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$6,899
2023
$7,771
2022
$4,588
2021
$4,879
2020
$3,493
2019
$6,839
2018
$3,202

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Nevro Corp.
$14,483
Abbott Laboratories
$7,864
PAINTEQ LLC
$1,760
BOSTON SCIENTIFIC CORPORATION
$1,337
Boston Scientific Corporation
$1,254
Teva Pharmaceuticals USA, Inc.
$1,162
Vertiflex, Inc.
$1,052
SI-BONE, Inc.
$993
Nalu Medical, Inc.
$910
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$731
ABBVIE INC.
$493
MML US, Inc.
$358
Amgen Inc.
$352
SPR Therapeutics, Inc
$338
Biohaven Pharmaceuticals, Inc.
$311
Saluda Medical Americas, Inc.
$285
BIOTRONIK NRO, Inc.
$277
SI-BONE, INC.
$254
Zyla Life Sciences
$234
Horizon Therapeutics plc
$202
AbbVie Inc.
$188
Almatica Pharma LLC
$185
Biohaven Pharmaceutical Holding Company Ltd.
$185
Medtronic, Inc.
$179
ASSERTIO THERAPEUTICS, Inc.
$176
Egalet US Inc
$176
Novartis Pharmaceuticals Corporation
$169
Vertos Medical, Inc.
$155
Horizon Pharma plc
$152
Collegium Pharmaceutical, Inc.
$127
Zyla Life Sciences, Inc.
$123
Medtronic USA, Inc.
$117
Stimwave Technologies Incorporated
$107
Assertio Therapeutics, Inc.
$107
Lundbeck LLC
$80
Daiichi Sankyo Inc.
$76
Scilex Pharmaceuticals Inc.
$68
Flowonix Medical Incorporated
$65
Averitas Pharma Inc.
$50
Vertical Pharmaceuticals, LLC
$48
PFIZER INC.
$47
Pernix Therapeutics Holdings, Inc.
$45
ARBOR PHARMACEUTICALS, INC.
$40
Lilly USA, LLC
$38
Azurity Pharmaceuticals, Inc.
$38
Spinal Simplicity, LLC
$37
Sentynl Therapeutics, Inc.
$30
UPSHER-SMITH LABORATORIES LLC
$27
IMPEL PHARMACEUTICALS INC.
$27
GRT US Holding, Inc.
$26
INSYS Therapeutics Inc
$22
IBSA Pharma Inc.
$20
BioDelivery Sciences International, Inc.
$20
US WorldMeds, LLC
$17
Flexion Therapeutics, Inc.
$17
Pacira Pharmaceuticals Incorporated
$13
RedHill Biopharma Inc.
$12
Allergan, Inc.
$12
Top 3 companies account for 64.0% of total payments
Associated products mentioned in payments ›
ADAPTIVESTIM · AIMOVIG · AJOVY · Aimovig · BUNAVAIL 2.1 mg 30-count box · BYSTOLIC · Belbuca · Cambia · DRG IPGs · DUEXIS · EMBLEM MRI S-ICD · EMGALITY · ETERNA · Evoke · GENERAL PAIN MANAGEMENT · GENERAL THERAPIES · GENERAL - PAIN MANAGEMENT · GENERAL PAIN MANAGEMENT · GRALISE · General - Pain Management · General - Therapies · Gralise · HA MINUTEMAN G3-R · HORIZANT · Horizant · IFUSE IMPLANT · INTELLIS · INTELLIS ADAPTIVESTIM · IONICRF · IonicRF Generator · Iovera · LORZONE · LYRICA · Levorphanol · Lucemyra/Lofexidine · METHYLPHENIDATE 72 · Morphabond ER · Movantik · NAPRELAN · NURTEC ODT · Nalu Neurostimulation System · Neuromodulation Dspsbls and Accs · Nucynta · OCTRODE · Omnia · PAINTEQ · PROCLAIM · Prism · Proclaim DRG IPG · Proclaim Family of SCS IPGs · Proclaim IPG · Prometra II · Prospera · Protege Family of SCS IPGs · QULIPTA · QUTENZA · Qutenza · RAYOS · RELISTOR · RELISTOR ORAL · ReActiv8 · SCS leads · SPECTRA WAVEWRITER · SPRINT PNS System · SPRIX · SUBSYS · SUPERION · Senza · Senza Spinal Cord Stimulation System · Superion · Superion ISS · Superion Indirect Decompression System · TOSYMRA · Tirosint · Trudhesa · UBRELVY · VANTA ADAPTIVESTIM · VYEPTI · Vanta · WAVEWRITER ALPHA · WaveWriter Alpha Prime 16 · XTAMPZA · ZIPSOR · ZOHYDRO ER · ZORVOLEX · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · Zilretta · Zipsor · iFuse Implant · mild Device Kit
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 1% for anesthesiology in TX.

Equivalent to $331 per 100 Medicare services performed
Looking for a anesthesiology in Schertz?
Compare anesthesiologys in the Schertz area by procedure volume, costs, and industry payment transparency.
Browse anesthesiologys nearby

Geographic Context

Anesthesiologys within 10 mi
466
Per 100K population
22.9
County median income
$70,571
Nearest hospital
LAUREL RIDGE TREATMENT CENTER
11.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Ybarra is a clinical cardiology specialist, with above-average Medicare volume (top 0% in TX), and high industry engagement (low-engagement, top 1%), with 17 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Ybarra experienced with dexamethasone injection (steroid)?
Based on Medicare claims data, Dr. Ybarra performed 2,622 dexamethasone injection (steroid) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Ybarra receive payments from pharmaceutical companies?
Yes. Dr. Ybarra received a total of $37,671 from 58 companies across 1,126 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ybarra's costs compare to other anesthesiologys in Schertz?
Dr. Ybarra's average Medicare payment per service is $67. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ybarra) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →